How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/age-related-macular-degeneration.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Age related macular degeneration — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Age related macular degeneration (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Age related macular degeneration, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Lucentis	Lucentis	Santen Inc.		Vascular endothelial growth factor A
BYOOVIZ	RANIBIZUMAB-NUNA	SAMSUNG BIOEPIS CO LTD		Vascular endothelial growth factor A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Age related macular degeneration
SAMSUNG BIOEPIS CO LTD · 1 drug in Age related macular degeneration
Santen Inc. · 1 drug in Age related macular degeneration

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Age related macular degeneration:

Cite this brief

Drug Landscape (2026). Age related macular degeneration — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/age-related-macular-degeneration. Accessed 2026-06-10.

Age related macular degeneration full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing